1887

Abstract

Human papillomavirus (HPV) type 16 is implicated in the aetiology of anogenital dysplasia which may progress to malignancy. HPV-16 DNA is actively transcribed in cervical carcinomas, the most abundant transcripts being from the E6 and E7 early open reading frames. The E7 protein has been shown to have transforming activity In this report we define four immunodominant B epitopes within the protein corresponding to the E7 gene, using a panel of murine monoclonal antibodies. Three epitopes are linear and lie within the N-terminal region of the molecule, and are unique to the HPV-16 E7 protein. One epitope is non-linear and presumed to be conformational. At least three of the four epitopes of the E7 protein are detectable by immunoprecipitation from an HPV-16- infected cervical carcinoma cell line. The demonstrated immunogenicity of the E7 protein allows us to deduce that this molecule may be a potential candidate for incorporation in a vaccine against cervical cancer.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-6-1347
1990-06-01
2021-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/6/JV0710061347.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-6-1347&mimeType=html&fmt=ahah

References

  1. Banks L., Spence P., Androphy E., Hubbert N., Matlashewski G., Murray A., Crawford L. 1987; Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. Journal of General Virology 68:1351–1359
    [Google Scholar]
  2. Berzofsky J. A. 1988; Immunodominance in T-lymphocyte recognition. Immunology Letters 18:83–92
    [Google Scholar]
  3. Burkhardt A., Di Maio D., Schlegel R. 1987; Genetic and biochemical definition of papillomavirus E5 transforming protein. EMBO Journal 6:2381–2385
    [Google Scholar]
  4. Campbell A. 1980; Monoclonal antibody technology. In Laboratory Techniques in Biochemistry and Molecular Biology Burdon R. H., Van Knippenberg P. H. Edited by Amsterdam: Elsevier;
    [Google Scholar]
  5. Cole S. T., Danos O. 1987; Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome; phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. Journal of Molecular Biology 193:599–608
    [Google Scholar]
  6. De Lisi C., Berzofsky J. A. 1985; T cell antigenic sites tend to be amphipathic structures. Proceedings of the National Academy of Sciences, U.S.A 82:7048–7072
    [Google Scholar]
  7. Dürst M., Kleinheinz A., Hotz M., Gissmann L. 1985; The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. Journal of General Virology 66:1515–1522
    [Google Scholar]
  8. Frazer I. H., Crapper R. M., Medley G., Brown T. C., Mackay I. R. 1986; Association between anorectal dysplasia, human papillomavirus and human immunodeficiency virus infection in homosexual men. Lancet ii:657–660
    [Google Scholar]
  9. Geysen H. M., Barteling S. J., Meloen R. H. 1985; Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against native protein. Proceedings of the National Academy of Sciences, U.S.A 82:178–182
    [Google Scholar]
  10. Geysen H. M., Rodda S. J., Mason T. J. 1986; A priori delineation of a peptide which mimics a discontinuous antigenic determinant. Molecular Immunology 23:709–715
    [Google Scholar]
  11. Geysen H. M., Rodda S. J., Mason T. J., Tribbick G., Schoofs P. G. 1987; Strategies for epitope analysis using peptide synthesis. Journal of Molecular Immunology 102:259–274
    [Google Scholar]
  12. Geysen H. M., Mason T. J., Rodda S. J. 1988; Cognitive features of continuous antigenic determinants. Journal of Molecular Recognition 1:32–39
    [Google Scholar]
  13. Gissmann L. 1984; Papillomaviruses and their association with cancer in animals and man. Cancer Surveys 3:162–181
    [Google Scholar]
  14. Gissmann L., Wolnik L., Ikenberg H., Koldovsky V., Schnurdi H., zur Hausen H. 1983; Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proceedings of the National Academy of Sciences, U.S.A 80:560–563
    [Google Scholar]
  15. Jenison S. A., Firzlaff J. M., Langenberg A., Galloway D. 1988; Identification of immunoreactive antigens of human papillomavirus type 6 by using Escherichia coli-expressed fusion proteins. Journal of Virology 62:2115–2123
    [Google Scholar]
  16. Jochmus-Kudielka I., Schneider A., Braun R., Kimmig R., Koldovsky U., Schneweis K. E., Seedorf K., Gissman L. 1989; Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. Journal of the National Cancer Institute 81:1698–1704
    [Google Scholar]
  17. Kirschner H. 1986; Immunobiology of human papillomavirus infection. Progress in Medical Virology 33:1–41
    [Google Scholar]
  18. Mallon R. G., Wojciechowicz S., Defendi V. 1987; DNA binding activity of papillomavirus proteins. Journal of Virology 61:1655–1660
    [Google Scholar]
  19. Matlashewski G., Schneider J., Banks L., Jones N., Murray A., Crawford L. 1987; Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO Journal 6:1741–1746
    [Google Scholar]
  20. Oltersdorf T., Seedorf K., Röwekamp W., Gissmann L. 1987; Identification of human papillomavirus type 16 E7 protein by monoclonal antibodies. Journal of General Virology 68:2933–2938
    [Google Scholar]
  21. Pirisi L., Yasumoto S., Feller M., Doniger J., Di Paolo J. A. 1987; Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. Journal of Virology 61:1061–1066
    [Google Scholar]
  22. Rothbard J. B., Taylor W. R. 1988; A sequence pattern common to T cell epitopes. EMBO Journal 7:93–100
    [Google Scholar]
  23. Schlegel R., Phelps W. C., Zhang Y.-L., Barbosa M. K. 1988; Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO Journal 7:3181–3187
    [Google Scholar]
  24. Seedorf K., Krammer G., Dürst M., Suhai S., Röwekamp W. 1985; Human papillomavirus type 16 DNA sequence. Virology 145:181–185
    [Google Scholar]
  25. Seedorf K., Oltersdorf T., Krammer G., Röwekamp W. 1987; Identification of early proteins of the human papillomaviruses type 16 (HPV16) and type 18 (HPV18) in cervical carcinoma cells. EMBO Journal 6:139–144
    [Google Scholar]
  26. Sheil A. G. R., Flavel S. 1986 In Ninth Report of the Australian and New Zealand Combined Dialysis and Transplant Registry pp. 104–112 Disney A. P. S. Edited by Woodville, South Australia: Queen Elizabeth Hospital;
    [Google Scholar]
  27. Singer H., Walker P. G., Mccance D. 1984; Genital wart virus infections: nuisance or potentially lethal?. British Medical Journal 288:735–736
    [Google Scholar]
  28. Smotkin D., Wettstein F. O. 1987; The major human papillomavirus protein in cervical cancers is a cytoplasmic phospho- protein. Journal of Virology 61:1686–1689
    [Google Scholar]
  29. Syrjanen K., Vlarynen I., Saarikoski S., Mantyjarvi R., Parkkinen P., Hippelainen N., Castren O. 1985; Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up. British Journal of Obstetrics and Gynaecology 92:1086–1092
    [Google Scholar]
  30. Yasumoto S., Burkhard A., Doniger J., Di Paolo J. A. 1986; Human papillomavirus type 16 DNA-induced malignant transformation of NIH-3T3 cells. Journal of Virology 57:572–577
    [Google Scholar]
  31. Yee C. L., Krishnan-Hewlett J., Baker C. C., Schegel R., Howley P. M. 1985; Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. American Journal of Pathology 119:3261–3266
    [Google Scholar]
  32. zur Hausen H., Schneider A. 1987; The role of papillomaviruses in human anogenital cancer. In Papovaviridae: The Papillomaviruses pp. 245–263 Howley P. M., Salzman N. P. Edited by New York: Plenum Press;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-6-1347
Loading
/content/journal/jgv/10.1099/0022-1317-71-6-1347
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error